FTC Pushes For Separate Trial In AndroGel Antitrust Suit
The Federal Trade Commission has said it wants a separate trial from private buyers and retailers in a decade-old antitrust suit over whether drugmakers conspired to delay generic versions of testosterone...To view the full article, register now.
Already a subscriber? Click here to view full article